Why instos are getting keen on Chinese healthcare PE

Jun 19, 2020

More asset owners are looking to support healthcare private equity funds amid the pandemic. But aspiring funds also face rising competition, increasing asset costs and geopolitical risk.

Why instos are getting keen on Chinese healthcare PE

The global Covid-19 outbreak has directed more institutional investor attention towards healthcare-focused private equity funds, particularly those with a China focus.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to AsianInvestor

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

If you are a senior professional at a large institutional asset owner, such as a sovereign wealth fund or pension fund, please contact [email protected] for further assistance.

Questions?

See here for more information on licences and prices, or contact [email protected]